NetworkNewsBreaks – Redfund Capital Corp. (CSE:
Post# of 36
Redfund Capital (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF), with today’s announcement that the medical cannabis bill will go to the Knesset agenda, has commented on the potential of Israel to allow the medical export of its products to global markets. Redfund is in the process of compiling final due diligence protocols surrounding several identified Israeli clients to become portfolio companies to execute its growth strategy into North America and Europe. “We are looking to Israel as our next country to forge strong relationships with for our banking initiatives,” Redfund CEO Meris Kott stated in the news release. “Israel has always led with a strong generic drug footprint. I am looking forward to working closely with partners in Israel in the very near future and capitalizing on current opportunities.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer